AJANTA PHARMA PHILIPPINES INC — Montelukast Importer Profile
Pharmaceutical Importer · #11 buyer for Montelukast · $657.0K import value · 15 shipments · PHILIPPINES · DGFT Verified
AJANTA PHARMA PHILIPPINES INC is the #11 importer of Montelukast from India with $657.0K in import value and 15 verified shipments. AJANTA PHARMA PHILIPPINES INC holds a 0.4% market share in Montelukast imports based in PHILIPPINES. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, AJANTA PHARMA PHILIPPINES INC imports 7 pharmaceutical products worth $5.3M across 5 therapeutic categories.
AJANTA PHARMA PHILIPPINES INC — Montelukast Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Montelukast to AJANTA PHARMA PHILIPPINES INC?
Verified from 15 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AJANTA PHARMA LIMITED | $657.0K | 15 | 100.0% |
AJANTA PHARMA PHILIPPINES INC sources Montelukast from 1 verified Indian supplier based on 15 customs records. The primary supplier is AJANTA PHARMA LIMITED accounting for 100.0% of imports.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Nearest Montelukast Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | GLENMARK PHARMACEUTICALS EUROPE LTD | UNITED KINGDOM | $1.2M | 70 | $17.7K |
| 17 | ORION CORPORATION | FINLAND | $966.3K | 45 | $21.5K |
| 11 | AJANTA PHARMA PHILIPPINES INC ★ | PHILIPPINES | $750.0K | 15 | $50.0K |
| 5 | THE CATHAY DRUG CO. INC | PHILIPPINES | $550.0K | 11 | $50.0K |
AJANTA PHARMA PHILIPPINES INC ranks #11 among 1,324 Montelukast importers from India. Average shipment value of $50.0K compared to the market average of $23.1K. The closest competitors by value are GLENMARK PHARMACEUTICALS EUROPE LTD and ORION CORPORATION.
Where Does AJANTA PHARMA PHILIPPINES INC Import Montelukast To?
Destination countries from 15 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $657.0K | 15 | 100.0% |
AJANTA PHARMA PHILIPPINES INC imports Montelukast to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $657.0K.
What Montelukast Formulations Does AJANTA PHARMA PHILIPPINES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ALDUET 10/10[6288PACKx3x10=188640 TABS]EACH FILM COATED TAB CONT:MONTELUKAST SODIUM EQ. TO MONTELUKAST 10 MG AS PER INV | $70.9K | 2 |
| CO ALTRIA 10 5 MG TABLETS 56544PACKx3x10 1696320 TABS MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS EACH AS PER INV | $50.0K | 1 |
| CO-ALTRIA PED 5/5/MONTELUKAST 5 MG & LEV | $50.0K | 1 |
| CO-ALTRIA TAB 10/5MG[52080PACKX3X10=1562400TAB][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS]EACH UNCOATED AS PER INV | $50.0K | 1 |
| CO-ALTRIA PED CT 5/5MG[13014PACKX3X10=390420 TABS] [MONTELUKAST 5 MG AND LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG AS PER INV | $50.0K | 1 |
| CO-ALTRIA TAB 10/5MG[51888PACKX3X10=1556640 TABS][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS]EACH AS PER INV | $50.0K | 1 |
| CO-ALTRIA PED CT 5/5MG[12849PACK X3 X 10= 385470 TABS] [MONTELUKAST 5 MG AND LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG | $50.0K | 1 |
| CO-ALTRIA TAB 10/5MG[62481PACKX3X10=1874430 TABS][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS]EACH AS PER INV | $50.0K | 1 |
| CO-ALTRIA PED CT 5/5MG[12474 PACKx3x10=374220 TABS]MONTELUKAST 5 MG AND LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG AS PER INV | $50.0K | 1 |
| CO ALTRIA TAB 10 5MG 61824PACKx3x10 1854720 TABS MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS MONTELUKAST AS PER INV | $50.0K | 1 |
AJANTA PHARMA PHILIPPINES INC imports 14 distinct Montelukast formulations from India. The top formulation is ALDUET 10/10[6288PACKx3x10=188640 TABS]EACH FILM COATED TAB with 2 shipments worth $70.9K.
Who Are the Top Buyers of Montelukast from India and How Much Does AJANTA PHARMA PHILIPPINES INC Import?
India exported $30.6M worth of Montelukast through 6,431 shipments from 510 suppliers to 138 countries, serving 1,324 buyers globally. AJANTA PHARMA PHILIPPINES INC imports $657.0K of this total, accounting for 0.4% of India's Montelukast exports with 15 shipments from PHILIPPINES. This is verified from 15 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for AJANTA PHARMA PHILIPPINES INC's Montelukast Imports?
AJANTA PHARMA PHILIPPINES INC's average Montelukast order value is $43.8K per consignment, based on 15 shipments totaling $657.0K. AJANTA PHARMA PHILIPPINES INC is based in PHILIPPINES and ranks #11 among all Montelukast importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Montelukast to AJANTA PHARMA PHILIPPINES INC?
AJANTA PHARMA PHILIPPINES INC sources Montelukast from 1 verified Indian supplier: AJANTA PHARMA LIMITED ($657.0K, 100.0%). This is based on 15 customs records.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Other Montelukast Importers?
AJANTA PHARMA PHILIPPINES INC ranks #11 among 1,324 Montelukast importers from India with a 0.4% market share. The top 3 importers are UNICHEM PHARMACEUTICALS (USA) INC. ($5.6M), BREATHEFREE LANKA PVT LTD ($3.4M), UNICHEM PHARMACEUTICALS USA INC ($2.6M). AJANTA PHARMA PHILIPPINES INC processed 15 shipments from PHILIPPINES.
About AJANTA PHARMA PHILIPPINES INC
AJANTA PHARMA PHILIPPINES INC imports 7 products worth $5.3M. Beyond Montelukast, top products include Febuxostat, Cetirizine, Pioglitazone, Glimepiride, Fenofibrate. View the complete AJANTA PHARMA PHILIPPINES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Montelukast — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AJANTA PHARMA PHILIPPINES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AJANTA PHARMA PHILIPPINES INC's capped import value divided by total capped export value for Montelukast across all Indian exporters.
- 5.Verified Records: This page is backed by 15 individual customs records matching AJANTA PHARMA PHILIPPINES INC importing Montelukast, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 1,324+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Montelukast Import Data for AJANTA PHARMA PHILIPPINES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for AJANTA PHARMA PHILIPPINES INC's Montelukast imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AJANTA PHARMA PHILIPPINES INC
Full Company Profile →
7 products · $5.3M total trade · 5 categories
AJANTA PHARMA PHILIPPINES INC × Montelukast
Verified from customs records
Company Overview
Top Products by AJANTA PHARMA PHILIPPINES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AJANTA PHARMA PHILIPPINES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Montelukast. For current order-level data, contact TransData Nexus.